Pyridine Synthesis via Directed Aziridination of Phenols in Continuous Flow

连续流中苯酚直接氮丙啶化合成吡啶

基本信息

  • 批准号:
    9402418
  • 负责人:
  • 金额:
    $ 0.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-01 至 2018-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The pyridine heterocycle is a privileged motif that appears in countless natural products, drugs, and materials. As the most prevalent heterocyclic aromatic ring in chemical therapeutics, the pyridine motif is featured in a plethora of blockbuster drugs such as Xalkori, Prilosec, and Zytiga. Due to the enormous prevalence of pyridines in human life, new and innovative methodologies to access this motif remain highly sought after. Numerous preparative methods require specialized starting materials and also necessitate strictly defined substitution patterns, which limit structural diversity. Conversely, transforming readily available and inexpensive precursors, that have all substitution intact, directly to the pyridine scaffold would constitute a simple, flexible, and powerful means to access these frameworks. The proposed research aims to develop a directed aziridination methodology in a continuous flow reactor that would allow access to pyridines from readily available phenol starting materials. This transformation has been historically challenging because of the nonregioselective aziridination of the arene ring with nitrene sources, which leads to complex mixtures of products. This powerful new strategy will rely on a directed aziridination to provide regioselectivity in the event. Continuous flow techniques will prove critical to this key transformation in order to avoid various undesired reaction pathways by means that are unparalleled in standard batch synthesis. Finally, a ring contraction process would then furnish libraries of highly valued pyridines in a multi-step, one-flow approach.
项目总结/摘要 吡啶杂环是一种特殊的基序,出现在无数的天然产物、药物和药物中。 材料.作为化学治疗中最普遍的杂环芳环,吡啶基序是 在大量的重磅炸弹药物中,如Xalkori,Prilosec和Zytiga。特别巨大 由于吡啶类化合物在人类生活中的普遍存在,因此获得该基序的新的和创新的方法仍然非常重要。 追捧许多制备方法需要专门的起始材料,并且还需要严格的 定义的替代模式,限制了结构多样性。相反,转换现成的和 具有完整的所有取代基的廉价前体直接连接到吡啶骨架上将构成一种 简单、灵活、强大的方法来访问这些框架。这项研究旨在开发一种 在连续流动反应器中的定向氮杂环丙烷化方法, 容易获得的苯酚原料。这种转变在历史上一直具有挑战性,因为 芳烃环与氮烯源的非区域选择性氮杂环丙烷化,这导致以下物质的复杂混合物: 产品.这种强大的新策略将依赖于定向氮丙啶化,以提供事件中的区域选择性。 连续流技术将被证明是关键的这一关键转变,以避免各种不希望的 通过在标准分批合成中无与伦比的手段实现反应途径。最后,环收缩 然后,该工艺将以多步骤、单流程的方法提供高价值的吡啶文库。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Evan Styduhar其他文献

Evan Styduhar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Evan Styduhar', 18)}}的其他基金

Pyridine Synthesis via Directed Aziridination of Phenols in Continuous Flow
连续流中苯酚直接氮丙啶化合成吡啶
  • 批准号:
    9190712
  • 财政年份:
    2016
  • 资助金额:
    $ 0.18万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 0.18万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.18万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 0.18万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.18万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 0.18万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 0.18万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.18万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 0.18万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 0.18万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.18万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了